CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- 4 Open-market buy Director bought 45,750 shares at an average $4.84 ($221,350)
- 4 Open-market buy Exec VP of Tech Operations bought 27,500 shares at an average $4.22 ($116,110)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy General Counsel bought 2,525 shares at $4.03 ($10,176)
- 4 Open-market buy Director bought 15,000 shares at $4.08 ($61,160)
- 4 Open-market buy Chief Executive Officer bought 4,830 shares at $4.14 ($19,985)
- 4 Open-market buy Director bought 5,000 shares at $3.95 ($19,750)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $3.85 ($38,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy General Counsel bought 3,250 shares at $3.05 ($9,913)
- 4 Open-market buy Chief Executive Officer bought 3,500 shares at $2.61 ($9,135)
- 4 Option exercise Director acquired 7,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 26 · 515 filings